Evaluation of a viral DNA-protein immunization strategy against African swine fever in domestic pigs

African swine fever virus (ASFV) causes serious disease in domestic pigs for which there is no vaccine currently available. ASFV is a large DNA virus that encodes for more than 150 proteins, thus making the identification of viral antigens that induce a protective immune response difficult. Based on...

Descripción completa

Detalles Bibliográficos
Autores: Pérez-Núñez, Daniel, Sunwoo, Sun-Young, Sánchez, Elena G., Haley, Nicholas, García-Belmonte, Raquel, Nogal, Marisa, Morozov, Igor, Madden, Daniel, Gaudreault, Natasha N., Mur, Lina, Shivana, Vinay, Richt, Jüergen A., Revilla Novella, Yolanda
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/214533
Acceso en línea:http://hdl.handle.net/10261/214533
Access Level:acceso abierto
Palabra clave:African swine fever virus
Heterologous DNA-protein immunization
Plasmid-expressed antigen
Recombinant protein
Immune response
Immunopathology
Descripción
Sumario:African swine fever virus (ASFV) causes serious disease in domestic pigs for which there is no vaccine currently available. ASFV is a large DNA virus that encodes for more than 150 proteins, thus making the identification of viral antigens that induce a protective immune response difficult. Based on the functional roles of several ASFV proteins found in previous studies, we selected combinations of ASFV recombinant proteins and pcDNAs-expressing ASFV genes, to analyze their ability to induce humoral and cellular immune responses in pigs. Pigs were immunized using a modified prime-boost approach with combinations of previously selected viral DNA and proteins, resulting in induction of antibodies and specific cell-mediated immune response, measured by IFN-γ ELISpots. The ability of antibodies from pigs immunized with various combinations of ASFV-specific antigens to neutralize infection in vitro, and antigen-specific activation of the cellular immune response were analyzed.